Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Capital Expenditures: 2010-2024

Historic Capital Expenditures for EyePoint Pharmaceuticals (EYPT) over the last 15 years, with Dec 2024 value amounting to $4.1 million.

  • EyePoint Pharmaceuticals' Capital Expenditures fell 380.95% to -$101,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $169,000, marking a year-over-year increase of 29.01%. This contributed to the annual value of $4.1 million for FY2024, which is 16.34% up from last year.
  • According to the latest figures from FY2024, EyePoint Pharmaceuticals' Capital Expenditures is $4.1 million, which was up 16.34% from $3.5 million recorded in FY2023.
  • Over the past 5 years, EyePoint Pharmaceuticals' Capital Expenditures peaked at $4.1 million during FY2024, and registered a low of $156,000 during FY2021.
  • Over the past 3 years, EyePoint Pharmaceuticals' median Capital Expenditures value was $3.5 million (recorded in 2023), while the average stood at $3.2 million.
  • Its Capital Expenditures has fluctuated over the past 5 years, first slumped by 56.91% in 2021, then skyrocketed by 1,278.21% in 2022.
  • Yearly analysis of 5 years shows EyePoint Pharmaceuticals' Capital Expenditures stood at $362,000 in 2020, then crashed by 56.91% to $156,000 in 2021, then surged by 1,278.21% to $2.1 million in 2022, then skyrocketed by 62.00% to $3.5 million in 2023, then rose by 16.34% to $4.1 million in 2024.